Treatment of Critical Bleeds in Patients With Immune Thrombocytopenia: A Systematic Review
Saifur Rahman Chowdhury +45 more
openalex +1 more source
In a multi‐centre study of obeticholic acid in primary biliary cholangitis, 45% discontinued the drug over 4 years, with 11% moving to combination therapy (fibrates). Of those continuing, response rates increased from 37% (1 year) to 55% (4 years). Non‐response at 12 months and cirrhosis were independent predictors of liver‐related events.
Nadir Abbas +18 more
wiley +1 more source
Anticoagulant therapy in patients with cancer and thrombocytopenia. [PDF]
Szmit S +5 more
europepmc +1 more source
Recompensation is a heterogeneous and dynamic state in HBV‐related decompensated cirrhosis; The prognosis for patients with unstable recompensation was found to be worse compared to those with stable recompensation, but still better than patients without recompensation; Subclassification of recompensation has significant implications for prognosis and ...
Shuai Xia +19 more
wiley +1 more source
The efficacy and safety of thrombopoietin receptor agonists in solid tumors with chemotherapy-induced thrombocytopenia: a systematic review and network meta-analysis of randomized controlled trials. [PDF]
Lai Y +7 more
europepmc +1 more source
When, which and how to switch: Navigating JAK inhibitors in myelofibrosis
Navigating choice of JAK inhibitor (JAKi) therapy for patients with myelofibrosis who are JAKi‐naïve and for those who have previously been treated with a JAKi.
Jennifer O'Sullivan +2 more
wiley +1 more source
Characteristics and risk factors for thrombocytopenia in malignancy patients with pulmonary embolism: a case control study. [PDF]
Kong H +9 more
europepmc +1 more source
Correction to: Efficacy and Safety of Upadacitinib in a Case of Pediatric Acute Severe Ulcerative Colitis and Immune Thrombocytopenia. [PDF]
europepmc +1 more source
Inter-Observer Agreement and Laboratory Correlation of the 4T Scoring Model for Heparin-Induced Thrombocytopenia: A Single-Center Retrospective Study and Literature Review. [PDF]
Aljumaa RM +7 more
europepmc +1 more source

